Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total liabilities, at DKK 62.4M, followed by Belite Bio (DKK 68.7M) and Oruka Therapeutics (DKK 113.8M). Figures as of 18 Nov 2026, 16:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsDKK 62.4M
- Median
- DKK 14.2B
- Combined market value
- DKK 34.67T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | DKK 62.4M | DKK 36B | DKK 852.93 | 0.43% down | 233% up | ||
| 2 | Belite BioBLTE · Health Care | DKK 68.7M | DKK 43.8B | DKK 1,078.54 | 0.30% up | 31% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | DKK 113.8M | DKK 44.6B | DKK 656.92 | 0.03% up | 241% up | ||
| 4 | Edgewise TherapeuticsEWTX · Health Care | DKK 206.9M | DKK 30.7B | DKK 280.43 | 2.16% down | 88% up | ||
| 5 | Dianthus TherapeuticsDNTH · Health Care | DKK 255.8M | DKK 33B | DKK 586.62 | 1.08% down | 113% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | DKK 364.6M | DKK 55.8B | DKK 854.64 | 0.55% up | 46% up | ||
| 7 | Praxis Precision MedicinesPRAX · Health Care | DKK 407.5M | DKK 58.3B | DKK 2,086.38 | 0.31% up | 61% up | ||
| 8 | Spyre TherapeuticsSYRE · Health Care | DKK 426.4M | DKK 61.6B | DKK 648.46 | 1.39% up | 286% up | ||
| 9 | ErascaERAS · Health Care | DKK 484M | DKK 31.4B | DKK 89.42 | 5.58% down | 403% up | ||
| 10 | Summit TherapeuticsSMMT · Health Care | DKK 629.5M | DKK 57.9B | DKK 72.37 | 0.52% down | 36% down | ||
| 11 | Definium TherapeuticsDFTX · Health Care | DKK 734.8M | DKK 26.7B | DKK 194.72 | 2.79% down | 169% up | ||
| 12 | ABIVAXABVX · Health Care | DKK 976.9M | DKK 50B | DKK 570.94 | 2.00% up | 27% down | ||
| 13 | Corcept TherapeuticsCORT · Health Care | DKK 1.3B | DKK 50.6B | DKK 462.67 | 3.15% down | 8% down | ||
| 14 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 1.3B | DKK 51.4B | DKK 654.67 | 0.96% up | 126% up | ||
| 15 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 1.4B | DKK 55.3B | DKK 797.37 | 0.29% up | 13% up | ||
| 16 | Cogent BiosciencesCOGT · Health Care | DKK 2.1B | DKK 33.5B | DKK 192.64 | 1.45% up | 20% down | ||
| 17 | TG TherapeuticsTGTX · Health Care | DKK 2.8B | DKK 67.1B | DKK 444.19 | 3.89% up | 107% up | ||
| 18 | Roivant SciencesROIV · Health Care | DKK 2.8B | DKK 190.1B | DKK 262.39 | 0.58% down | 90% up | ||
| 19 | Travere TherapeuticsTVTX · Health Care | DKK 3.3B | DKK 32.9B | DKK 342.40 | 1.72% down | 44% up | ||
| 20 | Mirum PharmaceuticalsMIRM · Health Care | DKK 3.6B | DKK 40.7B | DKK 623.00 | 0.63% down | 31% up | ||
| 21 | Ligand PharmaceuticalsLGND · Health Care | DKK 3.7B | DKK 40.9B | DKK 2,046.97 | 2.19% up | 43% up | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | DKK 4.1B | DKK 47.9B | DKK 910.48 | 1.77% down | 7% down | ||
| 23 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 4.5B | DKK 64.3B | DKK 2,767.43 | 3.81% down | 24% down | ||
| 24 | AlkermesALKS · Health Care | DKK 4.6B | DKK 53.5B | DKK 318.13 | 2.66% up | 58% up | ||
| 25 | Legend BiotechLEGN · Health Care | DKK 5B | DKK 21.4B | DKK 110.18 | 0.31% up | 42% down | ||
| 26 | United TherapeuticsUTHR · Health Care | DKK 5.3B | DKK 168.1B | DKK 3,948.01 | 0.86% down | 23% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 6B | DKK 41.5B | DKK 293.31 | 0.07% up | 10% up | ||
| 28 | BioMarin PharmaceuticalBMRN · Health Care | DKK 10.3B | DKK 79.4B | DKK 409.83 | 2.73% up | 11% up | ||
| 29 | InsmedINSM · Health Care | DKK 10.4B | DKK 179.4B | DKK 817.69 | 1.58% down | 40% down | ||
| 30 | Ascendis PharmaASND · Health Care | DKK 11.1B | DKK 120.9B | DKK 1,842.91 | 0.33% down | 28% up | ||
| 31 | CytokineticsCYTK · Health Care | DKK 14.2B | DKK 48.6B | DKK 349.08 | 0.87% down | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 14.4B | DKK 85.2B | DKK 102.17 | 1.32% up | 5% up | ||
| 33 | BridgeBio PharmaBBIO · Health Care | DKK 20.5B | DKK 103.1B | DKK 529.15 | 1.05% up | 17% up | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | DKK 20.7B | DKK 31B | DKK 186.03 | 1.21% up | 64% down | ||
| 35 | PTC TherapeuticsPTCT · Health Care | DKK 21.2B | DKK 34.3B | DKK 410.58 | 0.23% down | 20% down | ||
| 36 | Amneal PharmaceuticalsAMRX · Health Care | DKK 25B | DKK 51.1B | DKK 146.66 | 1.85% up | 83% up | ||
| 37 | BeOne MedicinesONC · Health Care | DKK 26.1B | DKK 314.3B | DKK 2,751.82 | 2.34% down | 17% up | ||
| 38 | Alnylam PharmaceuticalsALNY · Health Care | DKK 28.5B | DKK 138.7B | DKK 1,035.90 | 2.92% down | 66% down | ||
| 39 | Elanco Animal HealthELAN · Health Care | DKK 46.4B | DKK 90.1B | DKK 180.20 | 2.24% up | 20% up | ||
| 40 | Vertex PharmaceuticalsVRTX · Health Care | DKK 47.6B | DKK 923.8B | DKK 3,643.65 | 0.04% up | 27% up | ||
| 41 | GenmabGMAB · Health Care | DKK 47.9B | DKK 215.1B | DKK 348.84 | 1.53% down | 70% up | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 50B | DKK 106.8B | DKK 1,663.29 | 1.35% up | 37% up | ||
| 43 | Regeneron PharmaceuticalsREGN · Health Care | DKK 63.4B | DKK 674.9B | DKK 6,523.69 | 0.10% down | 36% up | ||
| 44 | Royalty PharmaRPRX · Health Care | DKK 67.5B | DKK 269.4B | DKK 468.60 | 0.07% up | 78% up | ||
| 45 | ZoetisZTS · Health Care | DKK 82.7B | DKK 232.4B | DKK 572.00 | 0.50% up | 29% down | ||
| 46 | GrifolsGRFS · Health Care | DKK 91.6B | DKK 39.5B | DKK 57.99 | 1.45% down | 1% up | ||
| 47 | ViatrisVTRS · Health Care | DKK 153.3B | DKK 160.9B | DKK 140.38 | 0.68% up | 96% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 223.9B | DKK 335.8B | DKK 287.82 | 0.95% down | 74% up | ||
| 49 | Abbott LaboratoriesABT · Health Care | DKK 231.4B | DKK 1.24T | DKK 713.37 | 0.08% down | 17% down | ||
| 50 | Takeda PharmaceuticalTAK · Health Care | DKK 345.1B | DKK 465.3B | DKK 145.62 | 1.30% down | 54% up | ||
| 51 | Novo NordiskNVO · Health Care | DKK 353B | DKK 1.19T | DKK 269.52 | 2.87% down | 17% down | ||
| 52 | GSKGSK · Health Care | DKK 408.7B | DKK 667.2B | DKK 332.86 | 0.85% down | 6% up | ||
| 53 | SanofiSNY · Health Care | DKK 416.8B | DKK 774.3B | DKK 322.46 | 0.49% down | 4% down | ||
| 54 | NovartisNVS · Health Care | DKK 439.1B | DKK 2.01T | DKK 1,062.59 | 2.06% down | 25% up | ||
| 55 | AstraZenecaAZN · Health Care | DKK 445.6B | DKK 1.89T | DKK 1,221.04 | 1.74% down | 2% up | ||
| 56 | Bristol-Myers SquibbBMY · Health Care | DKK 487.7B | DKK 838.6B | DKK 410.27 | 1.92% down | 34% up | ||
| 57 | Merck & CoMRK · Health Care | DKK 574.1B | DKK 2.35T | DKK 952.00 | 2.61% down | 51% up | ||
| 58 | Eli LillyLLY · Health Care | DKK 585.9B | DKK 8.43T | DKK 9,462.18 | 1.96% down | 35% up | ||
| 59 | Johnson & JohnsonJNJ · Health Care | DKK 802.2B | DKK 4.52T | DKK 1,878.81 | 1.12% down | 38% up | ||
| 60 | PfizerPFE · Health Care | DKK 827.6B | DKK 1.09T | DKK 191.89 | 1.14% down | 14% up | ||
| 61 | AbbVieABBV · Health Care | DKK 935.4B | DKK 3.48T | DKK 1,970.61 | 1.29% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8180 DKK).
Questions and answers
Which pharmaceuticals have the lowest total liabilities?
Veradermics (DKK 62.4M), Belite Bio (DKK 68.7M) and Oruka Therapeutics (DKK 113.8M) have the lowest total liabilities of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:40 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of DKK 34.67T as of 18 Nov 2026, 16:40 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.